These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

226 related items for PubMed ID: 32407277

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2. Brivaracetam augments short-term depression and slows vesicle recycling.
    Yang X, Bognar J, He T, Mohammed M, Niespodziany I, Wolff C, Esguerra M, Rothman SM, Dubinsky JM.
    Epilepsia; 2015 Dec; 56(12):1899-909. PubMed ID: 26515103
    [Abstract] [Full Text] [Related]

  • 3. Association of synaptic density and cognitive performance in temporal lobe epilepsy: Humans and animals PET imaging study with [18F]SynVesT-1.
    Xiao L, Xiang S, Chen C, Zhu H, Zhou M, Tang Y, Feng L, Hu S.
    Psychiatry Clin Neurosci; 2024 Aug; 78(8):456-467. PubMed ID: 38804583
    [Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5. Brivaracetam Modulates Short-Term Synaptic Activity and Low-Frequency Spontaneous Brain Activity by Delaying Synaptic Vesicle Recycling in Two Distinct Rodent Models of Epileptic Seizures.
    Xing H, Han X, Xu S, Sun Z, Yang S.
    J Mol Neurosci; 2022 May; 72(5):1058-1074. PubMed ID: 35278193
    [Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7. Decreased expression of synaptic vesicle protein 2A, the binding site for levetiracetam, during epileptogenesis and chronic epilepsy.
    van Vliet EA, Aronica E, Redeker S, Boer K, Gorter JA.
    Epilepsia; 2009 Mar; 50(3):422-33. PubMed ID: 18717715
    [Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. Brivaracetam does not modulate ionotropic channels activated by glutamate, γ-aminobutyric acid, and glycine in hippocampal neurons.
    Niespodziany I, Rigo JM, Moonen G, Matagne A, Klitgaard H, Wolff C.
    Epilepsia; 2017 Nov; 58(11):e157-e161. PubMed ID: 28850675
    [Abstract] [Full Text] [Related]

  • 10. Narrative Review of Brivaracetam: Preclinical Profile and Clinical Benefits in the Treatment of Patients with Epilepsy.
    Klein P, Bourikas D.
    Adv Ther; 2024 Jul; 41(7):2682-2699. PubMed ID: 38811492
    [Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13. Further evidence for a differential interaction of brivaracetam and levetiracetam with the synaptic vesicle 2A protein.
    Wood MD, Sands ZA, Vandenplas C, Gillard M.
    Epilepsia; 2018 Sep; 59(9):e147-e151. PubMed ID: 30144048
    [Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15. Favorable adverse effect profile of brivaracetam vs levetiracetam in a preclinical model.
    Sanon NT, Gagné J, Wolf DC, Aboulamer S, Bosoi CM, Simard A, Messiet E, Desgent S, Carmant L.
    Epilepsy Behav; 2018 Feb; 79():117-125. PubMed ID: 29287214
    [Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. Epileptic pilocarpine-treated rats exhibit aberrant hippocampal EPSP-spike potentiation but retain long-term potentiation.
    Carpenter-Hyland E, Bichler EK, Smith M, Sloviter RS, Benveniste M.
    Physiol Rep; 2017 Nov; 5(21):. PubMed ID: 29138358
    [Abstract] [Full Text] [Related]

  • 18. Brivaracetam for the treatment of epilepsy.
    Schulze-Bonhage A.
    Expert Opin Pharmacother; 2011 Aug; 12(12):1959-66. PubMed ID: 21682662
    [Abstract] [Full Text] [Related]

  • 19. Effects of TRPV1 on the hippocampal synaptic plasticity in the epileptic rat brain.
    Saffarzadeh F, Eslamizade MJ, Ghadiri T, Modarres Mousavi SM, Hadjighassem M, Gorji A.
    Synapse; 2015 Jul; 69(7):375-83. PubMed ID: 25967571
    [Abstract] [Full Text] [Related]

  • 20. Differential expression of synaptic vesicle protein 2A after status epilepticus and during epilepsy in a lithium-pilocarpine model.
    Contreras-García IJ, Pichardo-Macías LA, Santana-Gómez CE, Sánchez-Huerta K, Ramírez-Hernández R, Gómez-González B, Rocha L, Mendoza Torreblanca JG.
    Epilepsy Behav; 2018 Nov; 88():283-294. PubMed ID: 30336420
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 12.